DxS and AstraZeneca Collaborate on Iressa® Diagnostic
By Taskin Ahmed
PharmaDeals Review: Vol 2009 Issue 8 (Table of Contents)
Published: 11 Aug-2009
DOI: 10.3833/pdr.v2009i8.1158 ISSN: 1756-7874
Section: Distribution & Marketing
Fulltext:
Abstract
DxS, a personalised medicine company has inked an agreement with AstraZeneca to commercialise its TheraScreen EGFR29 as a companion diagnostic kit with AstraZeneca’s non-small cell lung cancer drug, Iressa® (gefitnib)...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login on the top right purple box.
Copyright: PharmaVentures Ltd
RSS